Wellorithm Review

Wellorithm in one line: wide access and four formats, but thin trust signals

Wellorithm is a Miami-based GLP-1 telehealth service that stands out for two real reasons: it ships compounded medication to 49 states, and it gives you four ways to take it. Most compounded GLP-1 sellers offer an injection and stop there. Wellorithm lets you choose semaglutide or tirzepatide, and take either one as a weekly injection or as an oral dissolving tablet. If needles are the thing keeping you off a GLP-1, that oral option is a genuine draw. But before you sign up, you should know that the conveniences come bundled with some trust gaps we couldn't explain away, so read the whole thing.

The four-format menu is the real differentiator

The headline feature here is choice of delivery. Compounded semaglutide and compounded tirzepatide are each available as a self-administered weekly shot or as a tablet that dissolves under the tongue. The oral route is the unusual part — very few compounded providers offer a dissolving tablet, and for people who are squeamish about injecting themselves at home, it removes the single biggest barrier to starting.

• Compounded semaglutide — injectable or oral dissolving tablet
• Compounded tirzepatide — injectable or oral dissolving tablet
• All four are compounded, not the brand-name pens
• Available everywhere except Louisiana

One honest caveat on the tablets: oral GLP-1 delivery is harder to absorb reliably than an injection, and these are compounded formulations, not the FDA-tested oral products on the market. Convenience is real; assume the dosing is less predictable than a shot.

You can't see a price until you finish the quiz

This is the most frustrating part of shopping Wellorithm. There is no public price list — the company's pricing page now returns an error, and nothing on the site tells you what a month actually costs until you complete the intake quiz and get matched. The quiz itself is quick (Wellorithm advertises a roughly two-minute flow with asynchronous approval), but you're handing over health information before you ever see a number.

For context, the typical compounded GLP-1 program in our database runs around $169 a month. Wellorithm may land above or below that — we genuinely can't tell you, because they don't publish it. Treat any figure you see only after the quiz as the real one, and don't assume there's an introductory teaser rate unless the checkout screen shows you one in writing.

How the medical side is set up — and why we're cautious

Wellorithm markets board-certified specialists, virtual consultations, and 24/7 support with a dedicated phone line, and on paper that's a complete telehealth package. The onboarding is genuinely easy and the support access is better than a lot of bargain compounders offer.

Here's where we have to be straight with you. When we looked past the marketing, several things didn't add up. The patient portal is a white-label build running on a third-party B2B2C platform rather than Wellorithm's own system. The clinicians listed on the site specialize in fields like cardiac surgery, pediatrics, and gynecology — not obesity medicine or endocrinology — and no NPI numbers are provided to verify them. A second business address listed on the site points to a location that doesn't resolve to a real postal code. And the company's own blog is filled with content about rehabilitation and elderly care, not weight loss. None of these is proof of wrongdoing, but together they're more loose threads than we like to see on a service handling your prescriptions.

Trust, safety and the fine print

On the reassuring side, Wellorithm displays a LegitScript seal, carries a 4.7-out-of-5 Trustpilot rating across a few dozen reviews, and offers a results guarantee: if you haven't lost at least ten percent of your weight after sixteen weeks, you can claim a refund. There are no FDA warning letters on file against the company.

But we could not independently confirm the LegitScript certification, and there's no visible PCAB pharmacy accreditation to tell you where or how the compounding is done. The terms of service also cap the company's liability at a token amount — a fifty-dollar ceiling — which is a meaningful thing to accept when you're injecting a prescription medication. As Wellorithm itself states, compounded GLP-1s are not FDA-approved. For all of these reasons we rate our confidence in this provider as medium, not high, even though its 49-state footprint would normally earn it more. You can see how that grade is built on our scoring methodology page.

Who should consider Wellorithm — and who shouldn't

• Consider it if: you specifically want a compounded GLP-1 as an oral tablet, you live in one of the harder-to-serve states, and price transparency upfront isn't a dealbreaker
• Skip it if: you want verified prescriber credentials, published pricing before you share health data, or PCAB-accredited compounding you can confirm
• Definitely skip it if: you're in Louisiana — Wellorithm doesn't operate there at all

Bottom line

Wellorithm offers something most compounders don't: four medication formats including a needle-free tablet, across nearly every state, with easy onboarding and a sixteen-week results guarantee. Those are real, useful advantages. But the trust picture is uneven — hidden pricing, unverifiable prescriber credentials, a white-labeled platform, and a very low liability cap. If the oral option is the reason you're here, go in with eyes open, read the terms before you pay, and confirm the prescriber and pharmacy details directly before your first dose. For most shoppers, a provider with transparent pricing and verifiable accreditation is the safer first stop.

Worth pricing against Telos Rx ($49/month) and bmiMD ($99/month) before you commit — both sit close to Wellorithm on cost and formulation.